A number of peptides in the signature can readily be linked to the pathophysiology of AKI (e.g., alpha-1-antitrypsin (SERPINA1), calprotectin (S100A9), serum amyloid A (SAA) for inflammation, uromodulin (UMOD), albumin (ALB)). Here, S100A9 is linked to acute kidney injury.